Buckingham M: Skeletal muscle formation in vertebrates. Curr Opin Genet Dev. 2001, 11: 440-448. 10.1016/S0959-437X(00)00215-X.
Article
CAS
PubMed
Google Scholar
Puri PL, Sartorelli V: Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol. 2000, 185: 155-173. 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z.
Article
CAS
PubMed
Google Scholar
Black BL, Olson EN: Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol. 1998, 14: 167-196. 10.1146/annurev.cellbio.14.1.167.
Article
CAS
PubMed
Google Scholar
Aurade F, Pinset C, Chafey P, Gros F, Montarras D: Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype. Differentiation. 1994, 55: 185-192. 10.1046/j.1432-0436.1994.5530185.x.
Article
CAS
PubMed
Google Scholar
Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987, 51: 987-1000. 10.1016/0092-8674(87)90585-X.
Article
CAS
PubMed
Google Scholar
Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 1993, 75: 1351-1359. 10.1016/0092-8674(93)90621-V.
Article
CAS
PubMed
Google Scholar
Montarras D, Chelly J, Bober E, Arnold H, Ott MO, Gros F, Pinset C: Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol. 1991, 3: 592-600.
CAS
PubMed
Google Scholar
Kassar-Duchossoy L, Gayraud-Morel B, Gomes D, Rocancourt D, Buckingham M, Shinin V, Tajbakhsh S: Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature. 2004, 431: 466-471. 10.1038/nature02876.
Article
CAS
PubMed
Google Scholar
Kitzmann M, Fernandez A: Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci. 2001, 58: 571-579.
Article
CAS
PubMed
Google Scholar
Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 1995, 267: 1022-1024.
Article
CAS
PubMed
Google Scholar
Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbe JC, Lamb N, Fernandez A: cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol. 1999, 19: 3167-3176.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tintignac LA, Leibovitch MP, Kitzmann M, Fernandez A, Ducommun B, Meijer L, Leibovitch SA: Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res. 2000, 259: 300-307. 10.1006/excr.2000.4973.
Article
CAS
PubMed
Google Scholar
Tintignac LA, Sirri V, Leibovitch MP, Lecluse Y, Castedo M, Metivier D, Kroemer G, Leibovitch SA: Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol Cell Biol. 2004, 24: 1809-1821. 10.1128/MCB.24.4.1809-1821.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhang JM, Zhao X, Wei Q, Paterson BM: Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. Embo J. 1999, 18: 6983-6993. 10.1093/emboj/18.24.6983.
Article
PubMed Central
CAS
PubMed
Google Scholar
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995, 267: 1018-1021.
Article
CAS
PubMed
Google Scholar
Ott MO, Bober E, Lyons G, Arnold H, Buckingham M: Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development. 1991, 111: 1097-1107.
CAS
PubMed
Google Scholar
Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, Fernandez A: The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol. 1998, 142: 1447-1459. 10.1083/jcb.142.6.1447.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima Y: Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci. 1998, 111 ( Pt 6): 769-779.
CAS
Google Scholar
Song A, Wang Q, Goebl MG, Harrington MA: Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol. 1998, 18: 4994-4999.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lindon C, Montarras D, Pinset C: Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J Cell Biol. 1998, 140: 111-118. 10.1083/jcb.140.1.111.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lindon C, Albagli O, Domeyne P, Montarras D, Pinset C: Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol Cell Biol. 2000, 20: 8923-8932. 10.1128/MCB.20.23.8923-8932.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Murray AW, Kirschner MW: Cyclin synthesis drives the early embryonic cell cycle. Nature. 1989, 339: 275-280. 10.1038/339275a0.
Article
CAS
PubMed
Google Scholar
Clarke PR: Preparation of Xenopus Egg Extracts and Their Utilization in Cell Cycle Studies. Cell Cycle - Materials and Methods. Edited by: Pagano M. 1995, , Springer Lab Manual, 103 -1116.
Google Scholar
Nurse P: Universal control mechanism regulating onset of M-phase. Nature. 1990, 344: 503-508. 10.1038/344503a0.
Article
CAS
PubMed
Google Scholar
Glotzer M, Murray AW, Kirschner MW: Cyclin is degraded by the ubiquitin pathway. Nature. 1991, 349: 132-138. 10.1038/349132a0.
Article
CAS
PubMed
Google Scholar
Solomon MJ, Glotzer M, Lee TH, Philippe M, Kirschner MW: Cyclin activation of p34cdc2. Cell. 1990, 63: 1013-1024. 10.1016/0092-8674(90)90504-8.
Article
CAS
PubMed
Google Scholar
Castro A, Peter M, Magnaghi-Jaulin L, Vigneron S, Galas S, Lorca T, Labbe JC: Cyclin B/cdc2 induces c-Mos stability by direct phosphorylation in Xenopus oocytes. Mol Biol Cell. 2001, 12: 2660-2671.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lorca T, Abrieu A, Means A, Doree M: Ca2+ is involved through type II calmodulin-dependent protein kinase in cyclin degradation and exit from metaphase. Biochim Biophys Acta. 1994, 1223: 325-332. 10.1016/0167-4889(94)90091-4.
Article
CAS
PubMed
Google Scholar
Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, Harvey RP, Graham RM: Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature. 1999, 400: 576-581. 10.1038/23054.
Article
CAS
PubMed
Google Scholar
Nash P, Tang X, Orlicky S, Chen Q, Gertler FB, Mendenhall MD, Sicheri F, Pawson T, Tyers M: Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature. 2001, 414: 514-521. 10.1038/35107009.
Article
CAS
PubMed
Google Scholar
Deshaies RJ, Ferrell JEJ: Multisite phosphorylation and the countdown to S phase. Cell. 2001, 107: 819-822. 10.1016/S0092-8674(01)00620-1.
Article
CAS
PubMed
Google Scholar
Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem. 1998, 67: 425-479. 10.1146/annurev.biochem.67.1.425.
Article
CAS
PubMed
Google Scholar
Holloway SL, Glotzer M, King RW, Murray AW: Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell. 1993, 73: 1393-1402. 10.1016/0092-8674(93)90364-V.
Article
CAS
PubMed
Google Scholar
Hershko A, Ciechanover A, Varshavsky A: Basic Medical Research Award. The ubiquitin system. Nat Med. 2000, 6: 1073-1081. 10.1038/80384.
Article
CAS
PubMed
Google Scholar
Deshaies RJ: SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol. 1999, 15: 435-467. 10.1146/annurev.cellbio.15.1.435.
Article
CAS
PubMed
Google Scholar
King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW: A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 1995, 81: 279-288. 10.1016/0092-8674(95)90338-0.
Article
CAS
PubMed
Google Scholar
Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, Ruderman JV, Hershko A: The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell. 1995, 6: 185-197.
Article
PubMed Central
CAS
PubMed
Google Scholar
King RW, Glotzer M, Kirschner MW: Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol Biol Cell. 1996, 7: 1343-1357.
Article
PubMed Central
CAS
PubMed
Google Scholar
Castro A, Arlot-Bonnemains Y, Vigneron S, Labbe JC, Prigent C, Lorca T: APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep. 2002, 3: 457-462. 10.1093/embo-reports/kvf095.
Article
PubMed Central
CAS
PubMed
Google Scholar
Castro A, Vigneron S, Bernis C, Labbe JC, Lorca T: Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway. Mol Cell Biol. 2003, 23: 4126-4138. 10.1128/MCB.23.12.4126-4138.2003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Geley S, Kramer E, Gieffers C, Gannon J, Peters JM, Hunt T: Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol. 2001, 153: 137-148. 10.1083/jcb.153.1.137.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brassac T, Castro A, Lorca T, Le Peuch C, Doree M, Labbe JC, Galas S: The polo-like kinase Plx1 prevents premature inactivation of the APC(Fizzy)-dependent pathway in the early Xenopus cell cycle. Oncogene. 2000, 19: 3782-3790. 10.1038/sj.onc.1203724.
Article
CAS
PubMed
Google Scholar
Vodermaier HC: APC/C and SCF: controlling each other and the cell cycle. Curr Biol. 2004, 14: R787-96. 10.1016/j.cub.2004.09.020.
Article
CAS
PubMed
Google Scholar
Shteinberg M, Protopopov Y, Listovsky T, Brandeis M, Hershko A: Phosphorylation of the cyclosome is required for its stimulation by Fizzy/cdc20. Biochem Biophys Res Commun. 1999, 260: 193-198. 10.1006/bbrc.1999.0884.
Article
CAS
PubMed
Google Scholar
Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM: Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell. 2000, 11: 1555-1569.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lorca T, Castro A, Martinez AM, Vigneron S, Morin N, Sigrist S, Lehner C, Doree M, Labbe JC: Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. Embo J. 1998, 17: 3565-3575. 10.1093/emboj/17.13.3565.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schmidt A, Duncan PI, Rauh NR, Sauer G, Fry AM, Nigg EA, Mayer TU: Xenopus polo-like kinase Plx1 regulates XErp1, a novel inhibitor of APC/C activity. Genes Dev. 2005, 19: 502-513. 10.1101/gad.320705.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lindon C, Albagli O, Pinset C, Montarras D: Cell density-dependent induction of endogenous myogenin (myf4) gene expression by Myf5. Dev Biol. 2001, 240: 574-584. 10.1006/dbio.2001.0435.
Article
CAS
PubMed
Google Scholar
Abu Hatoum O, Gross-Mesilaty S, Breitschopf K, Hoffman A, Gonen H, Ciechanover A, Bengal E: Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol Cell Biol. 1998, 18: 5670-5677.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL: E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene. 2005, 24: 6376-6384.
CAS
PubMed
Google Scholar
Margottin-Goguet F, Hsu JY, Loktev A, Hsieh HM, Reimann JD, Jackson PK: Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell. 2003, 4: 813-826. 10.1016/S1534-5807(03)00153-9.
Article
CAS
PubMed
Google Scholar
Reed SI: Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol. 2003, 4: 855-864. 10.1038/nrm1246.
Article
CAS
PubMed
Google Scholar
Tunquist BJ, Maller JL: Under arrest: cytostatic factor (CSF)-mediated metaphase arrest in vertebrate eggs. Genes Dev. 2003, 17: 683-710. 10.1101/gad.1071303.
Article
CAS
PubMed
Google Scholar
Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, Niederberger E, Tang W, Eisenbrand G, Meijer L: Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1999, 1: 60-67. 10.1038/9035.
Article
CAS
PubMed
Google Scholar
Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM, Eisenbrand G, Meijer L: Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J Biol Chem. 2001, 276: 251-260. 10.1074/jbc.M002466200.
Article
CAS
PubMed
Google Scholar
Meijer L, Raymond E: Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res. 2003, 36: 417-425. 10.1021/ar0201198.
Article
CAS
PubMed
Google Scholar
Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem. 1997, 243: 527-536. 10.1111/j.1432-1033.1997.t01-2-00527.x.
Article
CAS
PubMed
Google Scholar
De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH: Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem. 1997, 243: 518-526. 10.1111/j.1432-1033.1997.0518a.x.
Article
CAS
PubMed
Google Scholar
Meksuriyen D, Cordell GA: Biosynthesis of staurosporine, 1. 1H- and 13C-NMR assignments. J Nat Prod. 1988, 51: 884-892. 10.1021/np50059a012.
Article
CAS
PubMed
Google Scholar
Yagi Y, Sotani T, Nagao T, Horio T, Yamamoto I, Gohda E: Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition. Biochem Pharmacol. 2003, 66: 1797-1808. 10.1016/S0006-2952(03)00547-1.
Article
CAS
PubMed
Google Scholar
Duncia JV, Santella JB, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun JH, Earl RA, Tabaka AC, Teleha CA, Blom KF, Favata MF, Manos EJ, Daulerio AJ, Stradley DA, Horiuchi K, Copeland RA, Scherle PA, Trzaskos JM, Magolda RL, Trainor GL, Wexler RR, Hobbs FW, Olson RE: MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett. 1998, 8: 2839-2844. 10.1016/S0960-894X(98)00522-8.
Article
CAS
PubMed
Google Scholar
Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998, 273: 18623-18632. 10.1074/jbc.273.29.18623.
Article
CAS
PubMed
Google Scholar
Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991, 266: 15771-15781.
CAS
PubMed
Google Scholar
Kiss Z, Phillips H, Anderson WH: The bisindolylmaleimide GF 109203X, a selective inhibitor of protein kinase C, does not inhibit the potentiating effect of phorbol ester on ethanol-induced phospholipase C-mediated hydrolysis of phosphatidylethanolamine. Biochim Biophys Acta. 1995, 1265: 93-95. 10.1016/0167-4889(94)00242-7.
Article
PubMed
Google Scholar
Kronke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC: Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984, 81: 5214-5218.
Article
PubMed Central
CAS
PubMed
Google Scholar
Manger B, Hardy KJ, Weiss A, Stobo JD: Differential effect of cyclosporin A on activation signaling in human T cell lines. J Clin Invest. 1986, 77: 1501-1506.
Article
PubMed Central
CAS
PubMed
Google Scholar
Izumi T, Maller JL: Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity. Mol Biol Cell. 1995, 6: 215-226.
Article
PubMed Central
CAS
PubMed
Google Scholar